About Singleron
Singleron is a company based in Hagen (Germany) founded in 2018 by Jing Zhou and Nan Fang. Singleron has raised $84.48 million across 6 funding rounds from investors including Tencent, Arch Venture Partners and Lake Bleu Capital. Singleron has completed 1 acquisition, including Proteona. Singleron offers products and services including MobiuSCOPE Kit, PythoN i™, and Tensor System. Singleron operates in a competitive market with competitors including Arbor Biotechnologies, Mission Bio, Octant, Diagenode and Rebus Biosystems, among others.
- Headquarter Hagen, Germany
- Founders Jing Zhou, Nan Fang
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Singleron Biotechnologies Gmbh
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Singleron
Singleron offers a comprehensive portfolio of products and services, including MobiuSCOPE Kit, PythoN i™, and Tensor System.
Kit for full length single cell RNA sequencing applications
System for intelligent tissue processing in single cell analysis
Automated instrument for single cell library preparation
People of Singleron
Unlock access to complete
Funding Insights of Singleron
Singleron has successfully raised a total of $84.48M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Last Round
- First Round First Round
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2021 | Amount | Series B - Singleron | Valuation | Lake Bleu Capital , Firstred | |
| Dec, 2020 | Amount | Series A - Singleron | Valuation | Tencent | |
| Nov, 2020 | Amount | Series A - Singleron | Valuation |
investors |
Investors in Singleron
Singleron has secured backing from 15 investors, including venture fund and institutional investors. Prominent investors backing the company include Tencent, Arch Venture Partners and Lake Bleu Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Private equity fund focused on multiple sectors
|
Founded Year | Domain | Location |
Investments & Acquisitions by Singleron
Singleron has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Proteona.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Single cell proteogenomics-based therapeutics are developed and provided.
|
2016 |
Financial Statements - Singleron
Singleron Comparisons
Competitors of Singleron
Singleron operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Arbor Biotechnologies, Mission Bio, Octant, Diagenode and Rebus Biosystems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genomic technologies and drug discovery platforms are provided.
|
|
| domain | founded_year | HQ Location |
Single-cell multi-omics platform is provided for genotypic and phenotypic analysis.
|
|
| domain | founded_year | HQ Location |
Human cell interaction platform is provided for drug discovery.
|
|
| domain | founded_year | HQ Location |
Reagents and kits for epigenetics sequencing solutions are developed.
|
|
| domain | founded_year | HQ Location |
An imaging system for single-cell gene analysis is developed.
|
Latest news on Singleron
Frequently Asked Questions about Singleron
Singleron was founded in 2018.
Singleron is headquartered in Hagen, Germany. It is registered at Hagen, North Rhine-westphalia, Germany.
Nan Fang is the current CEO of Singleron. They have also founded this company.
Singleron is a funded company, having raised a total of $84.48M across 6 funding rounds to date. The company's 1st funding round was a Series A of $10M, raised on May 01, 2018.
Singleron was founded in 2018 and is based in Hagen, Germany. Operations are centered in the biotechnology sector, where single-cell multi-omics platforms are provided for clinical research and molecular diagnosis. A product portfolio is offered, including instruments, microfluidic devices, reagents, software analysis tools, and database solutions to enable high-throughput single-cell analysis. Single-cell sequencing services are also delivered.
Singleron's top competitors include Arbor Biotechnologies, Mission Bio and Zafrens.
Singleron offers MobiuSCOPE Kit, PythoN i™, and Tensor System.
Singleron has made 1 acquisition, including Proteona.
Singleron has 15 investors. Key investors include Tencent, Arch Venture Partners, Lake Bleu Capital, Firstred, and Sherpa Healthcare Partners.